猕猴输精管注射高分子聚合物HFMC的抗生育试验初报

本文介绍一种高分子聚合物HFMC注入输精管,遇体液即合成有孔隙（孔径2-16 μ）的固态聚合物,附着管壁并缓慢释放适度的H[+],以改变精子存活环境,从而达到狒猴非阻断性的输精管避孕。在狒猴配对试验中证明,输精管注入HFMC 30 mg×2（n=2）,在注射后47-50天精液品质即逐渐恢复,已有致孕能力;输精管注入HFMC 60 mg×2（n=4）,在300天后,有些个体精液品质才逐渐恢复,注后348-353天之间已有50%的雄猴配对致孕;另有50%的雄猴在注入854天时精液品质仍处于不育水平。实验结果还表明：HFMC对精子具有致死,致畸率高及使精子活力显著下降,这种作用随HFMC剂量的增大而加强,这种影响也随时间的后移而逐渐减弱;HFMC对输精管具有可通性及可复性。今后如能在注入剂量,自溶稳定性方面再改进,HFMC有可能成为男性节育较为理想的一种新型避孕剂。     

离乳大鼠假性性早熟模型的建立及对雌活性物质的应答

以雌激素含量明确的避孕药物作诱导剂观察了其对离乳Wistsar大鼠性成熟的影响,结果显示在给予避孕药后体重、乳腺、阴门、阴道上皮细胞、卵巢、子宫均发生类似人体假性性早熟变化,而肾上腺、脑垂体、甲状腺等与对照组比较均未见明显差异。     

Observations on parasitic gastroenteritis and bronchitis in grazing calves: effect of low level feed incorporation of morantel in early season.

Pott J. M., Jones R. M. and Cornwell R. I. 1979. Observations on parasitic gastroenteritis and bronchitis in grazing calves: effect of low level feed incorporation of morantel in early season. International Journal for Parasitology9: 153–157. Twenty-four castrated Friesian calves were divided into two equal groups on a body weight basis and grazed separate halves of an infected pasture. One group was given 1.5 mg/kg per day morantel tartrate in the feed over a period extending from 2 weeks before turning out in early May to early July. The other group of calves received an equivalent amount of unmedicated food as controls. Pasture larval counts showed a similar pattern and level of infection from February to July on both pastures. This consisted of a fall from moderate winter levels to very low levels in April/July. The control pasture then showed a typical sharp rise in August to high levels extending through September and falling to moderate levels in October. The pasture being grazed by treated calves showed only a small rise in larval counts in August. The total pasture contamination was reduced by 85% compared with controls during August/October. Faecal egg and larval counts showed similar differences between treated and control calves. Mild clinical signs of parasitic gastroenteritis and bronchitis were seen in controls but not in the treated group. The latter had a weight gain advantage of 20.5 kg the difference becoming marked in the last month of the trial.     

QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenic and treated with antipsychotic drugs.

Treatment of patients diagnosed as schizophrenic with antipsychotic drugs (neuroleptics) is known to cause occasional unexplained depletion of white blood cells, especially neutrophil granulocytes. It has been known for many years that neuroleptics can interfere with the mitochondrial respiratory chain in vitro. Because there has been a growing interest recently in mitochondrial targeting of drugs, and since a quantitative structure-activity relationship (QSAR) model that predicts mitochondrial accumulation of neuroleptics has been published, we investigated the effects of neuroleptics on white blood cell mitochondria. Venous blood samples were collected from both patients undergoing treatment with neuroleptics and healthy volunteers. The samples were processed for transmission electron microscopy. The resulting images of white blood cells were analyzed using stereology to compare quantitatively mitochondrial morphology in the patient and control groups. We found that in patients, but not in controls, there was swelling of mitochondria and fragmentation of the mitochondrial cristae. There also were fewer mitochondria in patients than in controls, although due to the swelling of the organelles, the volume density of mitochondria in the two groups was not significantly different. Such changes are typical of a toxic insult. Consequently, it seems plausible that, since schizophrenia is not a disease considered to affect white blood cells per se, these changes probably are due to the medication.     

百里香酚联合苯唑西林对耐甲氧西林金黄色葡萄球菌(MRSA)生物被膜的影响

【背景】耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)能以生物被膜的状态存在,从而产生多重耐药性和持续性感染。【目的】通过研究百里香酚和苯唑西林单用和联用对耐甲氧西林金黄色葡萄球菌生物被膜的形成抑制和清除作用,探究联合用药对MRSA生物被膜的影响,为临床联合应用抗MRSA药物提供理论依据。【方法】采用微量肉汤稀释法测定苯唑西林对MRSA标准菌株USA300的最低抑菌浓度;采用结晶紫染色法和菌落计数法评估百里香酚和苯唑西林单用和联用对USA300生物被膜形成抑制和清除作用。【结果】百里香酚和苯唑西林在亚抑菌浓度下对USA300生物被膜的形成具有一定的抑制作用。在较高浓度下,百里香酚对其24 h和72 h形成的生物被膜有良好的清除作用,而苯唑西林无清除作用。两药联用对生物被膜的抑制和清除作用进一步增强,在较低浓度下有较好的抑制和清除效果。【结论】百里香酚和苯唑西林联合用药与单独用药相比,对USA300的生物被膜的抑制和清除作用增强,两药联合有协同抗菌作用。     

以静脉药物配置中心为平台的静脉用药医嘱干预

目的 以静脉药物配置中心为平台,对用药医嘱进行分析和干预,提高用药医嘱的合理性,促进临床合理用药。方法 对静脉药物配置中心服务的6个病区用药医嘱中的不合理医嘱进行统计分析。结果 不合理医嘱明显减少,用药医嘱合理性大幅度提高差异有显著性（P＜0.01）。结论 通过对用药医嘱干预,能促进临床合理用药,保证患者用药安全。